XML 18 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows used in operating activities:    
Net loss $ (10,029,359) $ (2,574,613)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 13,698 3,926
Loss on disposal or sale of assets 6,761
Stock-based compensation expense 731,633 232,581
Common stock issued for advisory services 1,409,363
Non-cash interest expense 4,754 91,344
Changes in operating assets and liabilities:    
Prepaid expenses, deposits and other assets 17,712 8,642
Accounts payable, accrued expenses and other liabilities 356,124 300,522
Net cash used in operating activities (7,489,314) (1,937,598)
Cash flows provided by investing activities:    
Purchases of property and equipment (2,331) (10,944)
Maturities of certificates of deposit 2,500,000
Cash received in reverse merger transaction 8,500,602
Net cash provided by investing activities 8,498,271 2,489,056
Net increase in cash and cash equivalents 1,008,957 551,458
Cash and cash equivalents, beginning of period 1,997,192 2,336,519
Cash and cash equivalents, end of period 3,006,149 2,887,977
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of convertible notes and related accrued interest into common stock 711,495 0
Consideration in connection with RestorGenex Corporation merger transaction $ 21,261,000 $ 0